Clinical Trial Update: Gene Modulation of NLRP3, IL-1β and TNF-α in Peripheral Blood of Patients With Exogenous Obesity Treated With Berberine [NA]

View source ↗

Summary

A completed clinical trial assessing berberine's ability to modulate inflammatory genes (NLRP3, IL-1β, TNF-α) in the peripheral blood of individuals with obesit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: National Polytechnic Institute, Mexico | Conditions: Obesity, Overweight | NA | Status: COMPLETED